CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,294,876 | +9315.6% | 196,311 | +13254.5% | 0.01% | – |
| Q1 2023 | $24,373 | -83.6% | 1,470 | -97.1% | 0.00% | -100.0% |
| Q3 2020 | $149,000 | -91.3% | 50,000 | -94.3% | 0.00% | -90.0% |
| Q1 2017 | $1,711,000 | -28.3% | 877,266 | -61.4% | 0.01% | -41.2% |
| Q4 2016 | $2,386,000 | -7.5% | 2,272,816 | -4.0% | 0.02% | -5.6% |
| Q3 2016 | $2,580,000 | +53.5% | 2,366,964 | 0.0% | 0.02% | +63.6% |
| Q2 2016 | $1,681,000 | -36.5% | 2,366,964 | +4.6% | 0.01% | -45.0% |
| Q1 2016 | $2,648,000 | -52.5% | 2,263,576 | -0.6% | 0.02% | -56.5% |
| Q4 2015 | $5,578,000 | -15.7% | 2,276,923 | +3.2% | 0.05% | -11.5% |
| Q3 2015 | $6,619,000 | -53.7% | 2,206,264 | -36.3% | 0.05% | -47.5% |
| Q2 2015 | $14,306,000 | -49.7% | 3,463,805 | -47.3% | 0.10% | -49.0% |
| Q1 2015 | $28,439,000 | +173.6% | 6,568,000 | +87.7% | 0.19% | +165.8% |
| Q4 2014 | $10,395,000 | – | 3,500,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 5,517,885 | $22,789,000 | 2.29% |
| March Altus Capital Management LP | 80,890 | $334,000 | 1.94% |
| TANAKA CAPITAL MANAGEMENT INC | 111,693 | $462,000 | 1.15% |
| PURA VIDA INVESTMENTS, LLC | 395,000 | $1,951,000 | 1.00% |
| Broadfin Capital, LLC | 4,183,177 | $17,277,000 | 0.93% |
| Catalyst Capital Advisors LLC | 1,310,000 | $5,411,000 | 0.63% |
| SPHERA FUNDS MANAGEMENT LTD. | 1,200,000 | $4,956,000 | 0.48% |
| Baker Brothers Advisors | 7,335,692 | $30,296,000 | 0.27% |
| TURNER INVESTMENTS LLC | 286,370 | $1,183,000 | 0.22% |
| Perceptive Advisors | 851,200 | $3,515,000 | 0.21% |